PubRank

Françoise Moreau-Gachelin

Author PubWeight™ 14.60‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Delocalization of the multifunctional RNA splicing factor TLS/FUS in hippocampal neurones: exclusion from the nucleus and accumulation in dendritic granules and spine heads. Neurosci Lett 2005 1.26
2 Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression. Blood 2005 1.20
3 Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors. Blood 2002 1.12
4 Kit-activating mutations cooperate with Spi-1/PU.1 overexpression to promote tumorigenic progression during erythroleukemia in mice. Cancer Cell 2005 1.01
5 Spi-1/PU.1 oncoprotein affects splicing decisions in a promoter binding-dependent manner. J Biol Chem 2006 0.93
6 Spi-1 and Fli-1 directly activate common target genes involved in ribosome biogenesis in Friend erythroleukemic cells. Mol Cell Biol 2009 0.90
7 Spi-1/PU.1 oncogene accelerates DNA replication fork elongation and promotes genetic instability in the absence of DNA breakage. Cancer Res 2010 0.90
8 Cotargeting signaling pathways driving survival and cell cycle circumvents resistance to Kit inhibitors in leukemia. Blood 2012 0.86
9 Spi-1/PU.1 activates transcription through clustered DNA occupancy in erythroleukemia. Nucleic Acids Res 2012 0.85
10 Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood 2007 0.84
11 Ezrin is a target for oncogenic Kit mutants in murine erythroleukemia. Blood 2008 0.84
12 PU.1/Spi-1 binds to the human TAL-1 silencer to mediate its activity. J Mol Biol 2005 0.83
13 Erythropoietin down-regulates stem cell factor receptor (Kit) expression in the leukemic proerythroblast: role of Lyn kinase. PLoS One 2009 0.81
14 From mice to human: the "two-hit model" of leukemogenesis. Cell Cycle 2006 0.81
15 Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells. Oncogene 2004 0.80
16 Oncogenic kit triggers Shp2/Erk1/2 pathway to down-regulate the pro-apoptotic protein Bim and to promote apoptosis resistance in leukemic cells. PLoS One 2012 0.76